-
CHIR 99021: Tunable Organoid Translation
2026-08-28
A mechanistic and strategic guide to using CHIR 99021 trihydrochloride as a selective GSK-3 inhibitor in organoid, stem cell, insulin signaling, and metabolic research. The article connects pathway control with experimental design, translational limits, and scalable model development.
-
VER 155008: HSP 70 Inhibitor Workflows
2026-08-28
Build a practical VER 155008 workflow that separates direct Hsp70 ATPase inhibition from downstream apoptosis, client-protein loss, and cell-entry phenotypes. The guide connects cancer-cell assays with the HSC70-dependent internalization mechanism described in a TGEV reference study while clearly defining translational limits.
-
HyperScript First-Strand cDNA Synthesis Kit Guide
2026-08-27
Translate difficult RNA samples from neuropathic-pain models into dependable cDNA for PCR amplification and qPCR reaction design. Primer flexibility, thermal stability, and support for long transcripts make this workflow especially useful for low copy gene reverse transcription and structured RNA templates.
-
Recombinant Human Growth Hormone Assay Workflows
2026-08-27
Build more interpretable proliferation, chondrocyte differentiation, and signaling experiments with a defined somatotropin stimulus. This workflow connects growth hormone receptor activation to the IGFBP2–THBS1–IGF-1 mechanism while offering practical controls and troubleshooting guidance.
-
Cefepime (BMY-28142): A Model-Design Framework
2026-08-26
Cefepime (BMY-28142) supports integrated bacterial infection model design spanning cell-wall pharmacology, CNS compartment studies, and resistance surveillance. This evidence-led guide explains how to interpret cefepime experiments without confusing cefiderocol susceptibility data with direct cefepime efficacy.
-
Genotyping Kit: From Tissue to Mechanism
2026-08-26
The Genotyping Kit for target alleles streamlines genomic DNA preparation for PCR while supporting stronger genotype-to-phenotype studies. This article connects rapid single-tube genotyping with mechanistic evidence from Lactobacillus gasseri research and explains where the workflow fits—and where orthogonal validation remains essential.
-
BPN-19186: sEH–Nrf2 Research Workflows
2026-08-25
BPN-19186 supports a tiered strategy for testing soluble epoxide hydrolase, lipid-epoxide metabolism, Nrf2 signaling, and osteoclast differentiation. Its organic-solvent solubility makes it practical for biochemical screening and cell-based follow-up, while the reference study provides a model for connecting enzyme inhibition studies with metabolite, inflammatory, and transcriptional readouts.
-
Vardenafil HCl Trihydrate: Assay Guide
2026-08-25
Learn how Vardenafil HCl Trihydrate (SKU A4323) can be integrated into PDE5 inhibition, cGMP signaling, smooth muscle relaxation, and cell-assay workflows without confusing biochemical potency with cytotoxicity. The guide covers formulation, controls, interpretation, and practical vendor-selection criteria.
-
Glycogen, Timing, and Translational Metabolism
2026-08-24
Circadian exercise research shows why glycogen measurements must be interpreted alongside training time, tissue, and metabolic adaptation. This thought-leadership article explains how the Glycogen Colorimetric Assay Kit II can support rigorous glycogen quantification, high-throughput study design, and translational research in exercise physiology, diabetes, and glycogen storage disease research.
-
LRPPRC–Dasatinib Synergy in OXPHOS-Dependent Cancer
2026-08-24
The reference study identifies Dasatinib as a synergistic partner for LRPPRC inhibition and proposes a dual-genome mechanism of oxidative phosphorylation disruption. Its findings connect mitochondrial transcript destabilization with suppression of nuclear-encoded OXPHOS genes, offering a mechanistic rationale for combination treatment in LRPPRC-high tumors while highlighting important translational uncertainties.
-
HyperScript First-Strand cDNA Synthesis Kit: Colitis RT-qPCR
2026-08-23
The HyperScript First-Strand cDNA Synthesis Kit supports rigorous RNA-to-data workflows for inflammatory bowel research. This article connects the ROS–MAPK findings of a CeO2 colitis study with primer selection, structured-template reverse transcription, and defensible qPCR interpretation.
-
Oridonin, Inflammation, and Esophageal Cancer
2026-08-22
Peng et al. report that oridonin attenuated esophageal pathology and inflammatory signaling in a 4-NQO mouse model, with effects associated with suppression of the TLR4/NF-κB/NLRP3 inflammasome axis. The study connects systemic inflammatory markers, blood-cell indices, tissue pathology, and tumor-associated molecular readouts, offering a mechanistic basis for further validation rather than clinical evidence of efficacy.
-
Tankyrase Inhibition Suppresses HCC via Hippo Signaling
2026-08-22
The reference study shows that XAV-939 and G007-LK suppress hepatocellular carcinoma cell growth while reducing YAP activity through stabilization of the YAP inhibitors AMOTL1 and AMOTL2. Its main contribution is to connect tankyrase inhibition with Hippo pathway regulation, extending mechanistic analysis beyond the canonical Wnt/β-catenin context.
-
Oligo (dT) 25 Beads for Immune Transcriptomics
2026-08-21
How polyA-selective magnetic capture can strengthen immune transcriptomics and translational Alzheimer’s disease research while preserving a clear view of assay limitations.
-
Munc18c–Syntaxin4 Control of Tumor Cell Invasion
2026-08-20
The reference study identifies Munc18c as a functional regulator of syntaxin4 during invadopodium formation, linking SNARE-mediated membrane trafficking with extracellular matrix invasion. Its combination of interaction assays, targeted peptide interference, imaging, and trafficking measurements provides a mechanistic framework for studying how MT1-MMP and EGFR reach invasive tumor-cell membranes.